![]() ![]() ![]() The objective of this general chapter is to limit the amounts of elemental contaminants in finished dietary supplement dosage forms labeled as conforming to USP or NF standards. This general chapter is not intended to set limits for dietary ingredients. Those limits are set in the corresponding individual monographs.
The focus of this general chapter is on the four major elements of toxicological concern: arsenic, cadmium, lead, and mercury. The extent of testing can be determined using a risk-based approach that takes into account the likelihood of contamination. Manufacturers should consider the presence of unexpected elemental contaminants to determine compliance.
LIMITS OF ELEMENTAL CONTAMINANTS The levels of elemental contaminants should be restricted as shown in Table 1 unless otherwise stated in the individual monograph. Specific monographs may provide different limits for articles that need to be consumed in large quantities.
Table 1
Arsenic may be measured using a nonspeciation procedure under the assumption that all arsenic contained in the supplement is in the inorganic form. Where the limit is exceeded using a nonspeciation procedure, compliance with the limit for inorganic arsenic shall be demonstrated on the basis of a speciation procedure. Methylmercury determination is not necessary when the content for total mercury is less than the limit for methylmercury.
OPTIONS FOR COMPLIANCE WITH THE LIMITS OF ELEMENTAL CONTAMINANTS In order for a dietary supplement finished dosage form to comply with the limits for elemental contaminants as described in this chapter, the level of elemental contaminant in the finished dietary supplement should be NMT the PDE. The following three options are available for determining compliance with the limits for elemental contaminants in dietary supplements.
Dietary Supplement Analysis Option
This option is generally applicable. In this option the finished dietary supplement dosage form is analyzed according to the procedures in the general chapter Elemental ImpuritiesProcedures
![]() ![]()
Analysis:
Proceed as directed below in this chapter.
Calculate the measured amount of each elemental contaminant, in µg/daily intake, as:
Result = MVSS × N
MVSS = measured amount of each elemental contaminant (µg/serving size) N = maximum daily intake of the supplement recommended in the labeling (servings/day)
Acceptance criteria:
The measured amount/daily intake is NMT the PDE value given in Table 1.
Individual Component Option
This option is applicable to finished dietary supplement dosage forms with a maximum daily intake of NMT 10 g of the dietary supplement finished product.
Analysis:
Unless otherwise specified in the individual monograph, proceed with the individual ingredient as directed below in this chapter.
Acceptance criteria:
The product meets the requirements when each component used to prepare the finished dietary supplement meets the limits given in Table 2.
Table 2
Summation Option
This option can be used for finished dietary supplement dosage forms that are consumed in quantities greater than 10 g/day or where the acceptance limit for any contaminant in any component of the dietary supplement exceeds the applicable Individual Component Limits.
Analysis:
Unless otherwise specified in the individual monograph, proceed with the individual ingredient as directed below in this chapter.
Calculate the amount of each elemental contaminant, in µg/daily intake, present in the finished dietary supplement dosage form:
Result = S(Ci × Wi) × N
Ci = elemental contaminant concentration in the individual component (µg/g) Wi = weight of each individual component per serving of the dietary supplement (g/serving) N = maximum daily intake of the supplement recommended in the labeling (servings/day)
Acceptance criteria:
The calculated amount of each elemental contaminant/daily intake is NMT the PDE value given in Table 1.
ANALYTICAL PROCEDURES FOR TOTAL ELEMENTAL CONTAMINANTS Performance-based methodology for analysis of total elemental contaminants in general chapter Elemental ImpuritiesProcedures
![]() ![]() ![]() ![]() ![]() ![]()
Analytical Procedure for Inorganic Arsenic
Where the level of total arsenic exceeds the limit recommended in this chapter, speciation may be used to determine the amount of inorganic arsenic present. The following procedure is suggested for determination of inorganic arsenic, but any validated procedure shown to give equivalent or better results can be used.
Apparatus
See Figure 1.
Reagents
Distillation-reducing solution:
30.0 g of potassium iodide in 100 mL of water. [NotePrepare fresh on the day of use. ]
Control:
6.0 µg of arsenic (As) (6.0 mL of Standard Arsenic Solution). [NoteUse this amount rather than the 3.0 mL specified for Standard Preparation in the general chapter Arsenic
![]() ![]()
Sample solution:
Transfer a 2.00-g sample that has previously been ground to pass through a 60-mesh screen to a distillation flask (A). To the flask add 35 mL of hydrochloric acid 6.6 N and 15 mL of Distillation-reducing solution, let stand for 5 min to ensure reduction of arsenic [As(V)], connect the flask to the receiver chamber (B), complete the assembly of the apparatus, and begin circulating tap water through the condenser (C). Half-fill the lower two bulbs of the splash head (D) with water. Maneuver the stopcock to cause the contents of the receiver chamber to drain into the distillation flask, heat the flask until the temperature above the solution reaches 100
![]() ![]() ![]() ![]() ![]() Close the stopcock, and add a second 35-mL portion of 6.6 N hydrochloride (HCl) and 15 mL of the Distillation-reducing solution through the thermometer opening to the distillation flask. Replace the thermometer, increase the temperature to 100
![]() ![]()
Analysis:
Determine the arsenic content by the ICP-MS procedure in Elemental ImpuritiesProcedures
![]() ![]() ![]() ![]()
Analytical Procedure for Methylmercury
Where methylmercury determination is required, the following procedure is suggested. However, any validated procedure shown to give equivalent or better results can be used.
Procedure 1
This procedure uses an aqueous extraction of the mercury species with an l-cysteine solution, HPLC separation of the derivatized mercury species with a mobile phase also containing l-cysteine, and ICP-MS detection.
Cysteine solution:
1% l-cysteine hydrochloride monohydrate in water
Mobile phase:
0.1% l-cysteine hydrochloride monohydrate and 0.1% l-cysteine free base in water
Standard stock solution:
1 µg/mL of mercury (Hg) as methylmercury chloride, and 1 µg of mercury (Hg) as mercury chloride in 5% hydrochloric acid containing 0.2 mg/mL of l-cysteine hydrochloride monohydrate
Standard solution:
2 ng/mL of mercury as methylmercury from Standard stock solution in Cysteine solution
Sample solutions
For supplements in tablet form:
Weigh, and finely powder a counted number of tablets. Transfer an accurately weighed portion of the powder equivalent to 0.5 times the daily recommended intake to a tared vial. Add 50.0 mL of Cysteine solution accurately weighed, cap the vial, and shake vigorously. Place the vial in a water bath at 60
![]()
For supplements in capsule form:
Weigh accurately NLT 20 capsules, and determine the average weight. Place a number of capsules equivalent to about 5 times the daily recommended intake in a blender, add 500.0 mL of Cysteine solution and blend to obtain a homogenous analytical suspension. Transfer 50.0 mL of this analytical suspension to a vial, cap the vial, and shake vigorously. Place the vial in a water bath at 60
![]()
For supplements in liquid form:
Weigh accurately an amount of the liquid equivalent to 0.5 times the daily recommended intake into a vial, and add 50.0 mL of Cysteine solution. Cap the vial, and shake vigorously. Place the vial in a water bath at 60
![]()
Chromatographic system
Mode:
LC
Detector:
ICP-MS at a mass-to-charge ratio of 202
Column:
4.6-mm × 15-cm; 4-µm packing L1
Flow rate:
1 mL/min
Injection volume:
50 µL
System suitability
Sample:
Standard solution
Suitability requirements
Resolution:
NLT 3 between the peak representing mercury (Hg2+) species at a relative retention time of about 0.56 and the peak representing methylmercury (MeHg+) species at a relative retention time of 1.0
Relative standard deviation:
NMT 10.0%, Standard solution
Analysis
Samples:
Standard solution and the appropriate Sample solution
Determine the peak area of the peak representative of methylmercury in the chromatograms of the Sample solution and Standard solution.
Acceptance criteria:
0.2 µg/daily intake: The peak area for methylmercury in the chromatogram of the Sample solution is NMT the peak area for methylmercury in the chromatogram of the Standard solution.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP38NF33 Page 1783
Pharmacopeial Forum: Volume No. 39(5)
|